The IPO activity in the U.S. pharma/biotech sector has had a strong showing so far this year, with 69 listings compared to only 46 during the same period last year. In the third quarter, 34 companies belonging to the healthcare sector were listed on the major stock exchanges in the US.
from RTT - Biotech https://ift.tt/36pufdL
via IFTTT
No comments:
Post a Comment